verified SJR 1,748 · Q1 • database Scopus / SJR & Web of Science indexed

United States · American Association for Can...

workspace_premium Q1 — Molecular Biology lock Subscription

Molecular Cancer Research

Molecular Cancer Research is a journal indexed in SJR in Molecular Biology and Oncology with an H index of 156. It has an SJR impact factor of 1,748 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,748.

Molecular Cancer Research focuses its scope in these topics and keywords: cancer, cell, cells, prostate, gene, pancreatic, response, silencing, regulates, progression, ...

ISSN: 1541-7786

Publisher: American Association for Cancer Research Inc.

Category: Molecular Biology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,748 Q1

H-index 156

Acceptance rate pie_chart

22% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,748

H-index

156

Docs (year)

Docs 3y

443

Total refs

3803

Cites 3y

1946

Citable 3y

440

Cites/Doc 2y

4.32

Ref/Doc

48.76

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cathepsin G-Mediated Activation of Pro-Matrix Metalloproteinase 9 at the Tumor-Bone Interface Promotes Transforming Growth Factor- Signaling and Bone Destruction

Yin Yang 1 Regulates the Expression of Snail through a Distal Enhancer

Discovery-Based Protein Expression Profiling Identifies Distinct Subgroups and Pathways in Leiomyosarcomas

Differential Roles for the Interferon-Inducible IFI16 and AIM2 Innate Immune Sensors for Cytosolic DNA in Cellular Senescence of Human Fibroblasts

Differential Hypoxic Regulation of Hypoxia-Inducible Factors 1 and 2

Deubiquitinase OTUD6B Isoforms Are Important Regulators of Growth and Proliferation

Decreased eIF3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGF Signaling Pathway

Cyclooxygenase-2 (COX-2) Negatively Regulates Expression of Epidermal Growth Factor Receptor and Causes Resistance to Gefitinib in COX-2-Overexpressing Cancer Cells

Curcumin Affects Components of the Chromosomal Passenger Complex and Induces Mitotic Catastrophe in Apoptosis-Resistant Bcr-Abl-Expressing Cells

Constitutive Suppressor of Cytokine Signaling 3 Expression Confers a Growth Advantage to a Human Melanoma Cell Line

Cholesterol Regulates VEGFR-1 (FLT-1) Expression and Signaling in Acute Leukemia Cells

Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms

SHOW MORE ARTICLES

CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation

A Negative Feedback Regulatory Loop Associates the Tyrosine Kinase Receptor ERBB2 and the Transcription Factor GATA4 in Breast Cancer Cells

BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition

BAX/BAK-Independent Mitoptosis during Cell Death Induced by Proteasome Inhibition?

Batf Promotes Growth Arrest and Terminal Differentiation of Mouse Myeloid Leukemia Cells

Association of HO-1 and BRCA1 Is Critical for the Maintenance of Cellular Homeostasis in Prostate Cancer

Anti-Gout Agent Allopurinol Exerts Cytotoxicity to Human Hormone-Refractory Prostate Cancer Cells in Combination with Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand

Angiogenin Mediates Androgen-Stimulated Prostate Cancer Growth and Enables Castration Resistance

Analysis of mRNA Profiles after MEK1/2 Inhibition in Human Pancreatic Cancer Cell Lines Reveals Pathways Involved in Drug Sensitivity

Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers

Adaptation to HIF1a Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism

Activation of p38 Mitogen-Activated Protein Kinase Is Required for Death Receptor-Independent Caspase-8 Activation and Cell Death in Response to Sphingosine

FAQs

Molecular Cancer Research has an SJR of 1,748 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Molecular Cancer Research is 22%.

Molecular Cancer Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Molecular Cancer Research?

What is the APC / publication cost?

What is the acceptance rate?